CEO of pharma giant Sanofi says businesses should stop ‘AI washing' [Fortune]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Fortune
However, Paul Hudson, CEO of Sanofi , one of the world's leading biopharmaceutical companies, says executives may need to rein themselves in when it comes down to how they describe their AI capabilities. At Fortune's Global Forum in New York City Monday, Hudson warned that executives have often exaggerated how AI is used by their companies. “There is a lot of AI washing and CEOs talking about AI projects,” he said, alluding to the tactic of overselling AI's potential without thinking through how to mitigate its risks. “You have to have rules of the game,” Hudson said, touting Sanofi's AI ethical review board, which projects are required to go through. “We need to be a bit more sophisticated in how we calibrate the AI.” Sanofi, which ranks 297th on the Fortune Global 500, recently announced it would sell a 50% stake of its consumer healthcare business Opella in an effort to focus primarily on innovation within biopharma. For Hudson, AI's potential in health care falls into two
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition [Yahoo! Finance]Yahoo! Finance
- HHS Must End Unauthorized Administration Of 340B Drug-Discount Program [Forbes]Forbes
- Sanofi/Regeneron Pharmaceuticals' DUPIXENT Approval Marks a Significant Shift in Chronic Obstructive Pulmonary Disease Treatment Landscape | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales [Yahoo! Finance]Yahoo! Finance
- Recordati SpA (RICFY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]Yahoo! Finance
SNY
Analyst Actions
- 9/19/24 - Citigroup Inc.
SNY
Sec Filings
- 11/7/24 - Form SC
- 11/7/24 - Form 6-K
- 10/31/24 - Form 6-K
- SNY's page on the SEC website